bullish
China ADRs Secondary Listing - Pipeline Looks Rich, Have Three Years to Move
417 Views03 Feb 2021 11:15
2020 saw nine companies undertake a secondary listing in Hong Kong, to together raise over US$16bn. We shortlist remaining candidates and look at the updates since our previous note in May 2020.
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 7-minute read)
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- ECM Weekly (21 February 2021) - Tencent Lock-Up Expiry, SciClone Pharma, Joinn Lab, Bairong, Betta21 Feb 2021
- ECM Weekly (14 February 2021) - Youran Dairy, Bairong, Joinn Lab, Bilibili HK,15 Feb 2021
- Bilibili Secondary Listing Early Look - Will Probably Be More like JD and NetEase10 Feb 2021
- China ADRs Secondary Listing - Holding Foreign Companies Accountable Act - I'm Coming Home21 May 2020
- China ADRs Secondary Listing: COVID-19 Has Increased the Tension but Narrowed the Short List13 May 2020
- China ADRs Secondary Listing Deep-Dive: Yin and Yang25 Feb 2020
x